A plethora of treatment options exist for cancer therapeutics, but many are limited by side effects and either intrinsic or acquired resistance. The need for more effective targeted cancer treatment has led to the focus on forkhead box (FOX) transcription factors as possible drug targets. Forkhead factors such as FOXA1 and FOXM1 are involved in hormone regulation, immune system modulation, and disease progression through their regulation of the epithelial-mesenchymal transition. Forkhead factors can influence cancer development, progression, metastasis, and drug resistance. In this review, we discuss the various roles of forkhead factors in biological processes that support cancer as well as their function as pioneering factors and their potential as targetable transcription factors in the fight against cancer. ©2022 The Authors; Published by the American Association for Cancer Research.
Maria Castaneda, Petra den Hollander, Sendurai A Mani. Forkhead Box Transcription Factors: Double-Edged Swords in Cancer. Cancer research. 2022 Mar 22;82(11):2057-2065
PMID: 35315926
View Full Text